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Introduction {#sec1}
============

L1 retrotransposable elements (TEs) make up 15%--20% of the mammalian genomic DNA ([@bib12], [@bib35]). The mouse genome contains about 500,000 L1 copies, but only approximately 3,000 have retained the property to drive their expansion via a copy-paste mechanism ([@bib42]). Active elements (∼6.5 kb) are usually silenced by various mechanisms ([@bib14], [@bib29], [@bib40], [@bib41]), as they would be potentially disruptive by affecting genome structure and stability. However, recent reports indicate that L1 reactivation occurs in early development, before germ layer differentiation, and in the adult brain, revealing genomic mosaicism for L1 content in the soma ([@bib10], [@bib32], [@bib43], [@bib47], [@bib54]). In brain, L1 retrotransposition preferentially hits neuronal expressed genes, and L1-related structural variations include L1 *de novo* insertions as well as deletions of large fragments of genomic DNA ([@bib15], [@bib47], [@bib54]).

L1 mobilization might influence gene expression, contributing to phenotype variation ([@bib4], [@bib9], [@bib19], [@bib20], [@bib23], [@bib28]). In fact, somatic L1 retrotransposition has been extensively correlated to several pathogenic processes, such as neurological diseases, autoimmune disorders, and cancer ([@bib6], [@bib11], [@bib27], [@bib44], [@bib48], [@bib51]). Recent reports have shown that, even if rare ([@bib16], [@bib17]), L1 retrotransposition occurs in the adult hippocampus, and its inhibition impairs long-term memory formation ([@bib1]). In addition, L1 copy number variation (CNV) has been reported in a mouse model to be correlated with induced early-life stress ([@bib2]). Although the functional significance of this phenomenon remains to be elucidated, altogether this evidence indicates that L1 retrotransposition-induced genomic mosaicism occurs and influences brain function. The question remains open whether somatic L1 activation would be just a spurious event or a part of specific differentiation or more in general of developmental programs ([@bib9]).

In order to address this question, we used a post-mitotic somatic cell transdifferentiation model for direct conversion of mouse primary embryonic fibroblasts (MEFs) into induced neurons of the dopaminergic lineage (iDAs) ([@bib7]). Direct transdifferentiation converts a terminally differentiated cell into another one without pluripotency reinstatement (iPS), thus avoiding genome-wide heterochromatin erasure, aberrant retrotransposons reactivation, and preserving global epigenetic transcriptional regulation and genome integrity ([@bib8], [@bib21], [@bib22], [@bib26], [@bib36], [@bib56]). Using whole-genome sequencing (WGS), we report evidence for L1 reactivation and CNV upon cell identity conversion and a conserved and specific *de novo* insertion site profile involving iDA expressed gene loci. Further, RNA sequencing (RNA-seq) and assay for transposase-accessible chromatin sequencing (ATAC-seq) analysis revealed that L1 recipient loci show a more accessible chromatin in the proximity of L1 somatic insertion sites concomitant also with increased non-coding RNA (ncRNA) production. Finally, inhibition of L1 dynamics impaired iDA cell maturation, indicating a correlation between L1 reactivation and cell lineage conversion.

Results {#sec2}
=======

L1 Retrotransposition Occurs during Transdifferentiation of Mouse Embryonic Fibroblasts into Dopaminergic Neurons {#sec2.1}
-----------------------------------------------------------------------------------------------------------------

To verify L1 activity during cell transdifferentiation, we adopted a well-characterized protocol for direct conversion of post-mitotic MEFs to iDAs ([@bib7]) obtained by overexpression of three specific transcription factors (*Nurr1, Ascl1, and Lmx1a*) ([Figure 1](#fig1){ref-type="fig"}A). To optimize both production and isolation of fully transdifferentiated cells, we used MEFs carrying an enhanced green fluorescent protein (EGFP) reporter cassette under the control of tyrosine hydroxylase (*Th*) promoter. Reprogramming efficiency and cell conversion were confirmed by both immunofluorescence and real-time qPCR expression analysis of *En1, FoxoA1, FoxoA2, Tuj1*, and *Th* genes ([Figures 1](#fig1){ref-type="fig"}B and 1C).Figure 1L1 Dynamics Occurs during MEF Reprogramming into iDA Cells(A) Schematic representation of MEF transdifferentiation to iDA neurons. Expression of *Ascl1, Nurr1*, and *Lmx1a* is induced with doxycycline (dox) 24 h after infection. At 48 h post-induction, culture medium is replaced with a neuronal-inducing medium (NM).(B) Immunofluorescent assay for principal neural commitment (TH, TUJ1, and VMAT2) and dopaminergic neuron markers (TH).(C) Expression levels of iDA-specific transdifferentiation markers. Data are represented as mean with SEM. N = 6. T Test results are showed in the plot.(D) Expression levels of full-length (5′UTR) and truncated (L1-ORF2) L1 elements during MEF transdifferentiation. RNA expression was measured in non-infected (N.I.) cells, mock cells and after 2, 4, 7, 14 days upon transdifferentiation. SEM and one-way ANOVA (F and p value) are indicated; t test is also showed in the plot. n = 3.(E) Northern blot analysis of poly(A) + LINE-1 RNA. Levels of b-actin RNA have been used as loading control.(F) Amount of L1-ORF2 and L1-3′ UTR DNA, normalized on 5s rDNA content during transdifferentiation. SEM and one-way ANOVA are indicated. n = 6. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.(G) Western blot analysis of LINE-1 ORF2 and L1-ORF1 protein production. Levels of TBP protein have been used as loading control.

The expression of active L1 elements was measured by a multiplex TaqMan qPCR assay using an FAM-labeled probe specific for the L1 5′ UTR or L1-ORF2 region ([@bib2]), together with a VIC-labeled probe, for the detection of TBP mRNA as an internal normalizer ([Figure 1](#fig1){ref-type="fig"}D). We confirmed the production of full-length LINE-1 RNA in iDA cells by northern blot using a probe complementary to the 0--600 base pair (bp) region of the L1 5′ UTR transcript ([Figures 1](#fig1){ref-type="fig"}E and [S1](#mmc1){ref-type="supplementary-material"}B-left) ([@bib13]). Further, by western blot analysis, we verified the production of the ORF2 protein encoded by the polycistronic L1 full-length transcript on MEF and iDA cells. Total protein extracts were probed using a custom-made antibody specific for mouse L1-ORF2 and L1-ORF1 proteins. Consistently with the L1 RNA expression profile, the ORF2 protein signal is detectable from day 7, further increasing in fully transdifferentiated iDA cells ([Figures 1](#fig1){ref-type="fig"}F and [S1](#mmc1){ref-type="supplementary-material"}A).

The relative genome content of all L1 elements (both full length and 5′-truncated) was measured by a second set of TaqMan assays specific for the L1-ORF2 or L1- 3′ UTR DNA sequences ([@bib2]). Time-course experiments revealed a specific trend of reactivation and increase in CNV during cell conversion, starting from day 4 ([Figures 1](#fig1){ref-type="fig"}F and [S1](#mmc1){ref-type="supplementary-material"}B-right).

Then, we measured the L1 CNV in TH+ iDA cells and residual TH− cells; only the genome of fully transdifferentiated cells displayed a higher amount of L1 elements. In parallel, we compared the number of copies of L1s and other retrotransposable elements, such as active and autonomous intracisternal A-type particle (IAP) elements and non-autonomous SINE B1 and B2 elements. Notably, during transdifferentiation, only L1s and not other potentially mobile elements are expanding in the genome ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D).

Finally, to prove that transdifferentiating post-mitotic cells are compatible and support the retrotransposition machinery, we overexpressed two different exogenous mouse L1 element (pGF21 and pTN201 plasmids in wild-type MEF cells, which were generously provided by Prof. John Goodier) with an antisense oriented neomycin resistance cassette interrupted by an intron inside the 3′ UTR region ([@bib39], [@bib45]) ([Figure 2](#fig2){ref-type="fig"}A). We verified the integration of the exogenous L1 element by selecting neomycin-resistant cells. Neomycin-resistant iDA colonies were counted through a crystal violet staining assay ([Figures 2](#fig2){ref-type="fig"}B and 2C). Indeed, transdifferentiated iDA cells show a higher rate of pGF21 and pTN201 retrotransposition, confirming the L1 reactivation trend detected by qPCR and western blot.Figure 2L1-mNEOMYCINi Retrotransposition Assay(A) LINE1 retrotransposition assay with pGF21 and pTN201 L1-Neo reporter plasmids. The scheme depicts the rationale of the assay.(B) Retrotransposition of an engineered exogenous LINE1-Neomycin sequences in the genome has been evaluated by drug selection and crystal violet colony screening as in ([@bib39]). Plasmid expressing LINE1-*Neomycin* have been transfected in 3 independent preparation of MEF cells before induction of transdifferentiation. Electroporation efficiency is showed in the picture using a GFP track vector.(C) Quantification of neomycin-resistant cell colonies from crystal violet assay. n = 3, SEM and t test are indicated.

Block of L1 Dynamics Affects the Efficiency of iDA Cell Transdifferentiation {#sec2.2}
----------------------------------------------------------------------------

To investigate L1 reactivation events during the acquisition of *in vitro*-induced dopaminergic neuronal phenotype, we treated the fibroblasts undergoing conversion with either lamivudine (3TC), which blocks reverse transcriptase enzymes essential for L1 retrotransposition ([@bib57]), or 2-deoxy-2-fluoroarabinonucleic acid-modified antisense oligonucleotides (F-ANA ASO) to knock down full-length L1 RNA ([@bib1], [@bib51]) ([Figure 3](#fig3){ref-type="fig"}A).Figure 3LINE-1 Inhibition Severely Affects Fibroblast Transdifferentiation(A) Schematic representation of the transdifferentiation protocol under treatment with reverse transcriptase inhibitor Lamivudine(3TC) and LINE-1 anti sense oligonucleotide (L1-ASO) treatment.(B) Immunofluorescent assay for transdifferentiation efficiency (Th marker in green) in iDA cells treated with Lamivudine or L1-ASO compared to mock (1×PBS) or scramble ASO respectively. Nuclei were counterstained with DAPI (blue).(C) Number of transdifferentiated Th+ cells (green) upon 3TC or L1-ASO treatment. The plot shows the quantification of 6 fields from 3 independent experiments. Scale bar= 100 µm.(D) Expression levels of L1 full-length elements during MEF transdifferentiation. RNA expression was measured in non-infected cells (N.I.) and after 14 days of differentiation. SEM and two-tailed t test are indicated. n = 6.(E) Copy Number of L1 full-length elements during MEF transdifferentiation. L1 CNV was measured in non-infected cells (N.I.) and after 14 days of differentiation. SEM and two-tailed t test are indicated. n = 6.(F) Western Blot analysis of L1 ORF2 and L1-ORF1 protein production in wt and L1-ASO treated iDA cells. Level of TBP protein have been used as loading control.(G) Expression levels of *En1* gene in not infected (N.I.) cells and after 14 days of differentiation in 3TC or L1 ASO treated cells. SEM and two-tailed t test are indicated; n = 6.(H) Expression levels of *FoxoA1* gene in not infected (N.I.) cells and after 14 days of differentiation in 3TC or L1 ASO treated cells. SEM and two-tailed t test are indicated; n = 6.(I) Expression levels of *FoxoA2* gene in not infected (N.I.) cells and after 14 days of differentiation in 3TC or L1 ASO treated cells. SEM and two-tailed t test are indicated; n = 6.(J) Expression levels of *Tuj1* gene in not infected (N.I.) cells and after 14 days of differentiation in 3TC or L1 ASO treated cells. SEM and two-tailed t test are indicated; n = 6.(K) Expression levels of *Th* gene in not infected (N.I.) cells and after 14days of differentiation in 3TC or L1 ASO treated cells. SEM and two-tailed t test are indicated; n = 6.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

Inhibition of L1 retrotransposition with either 3TC or ASO reduced the number of TH positive cells by 30%--35% ([Figures 3](#fig3){ref-type="fig"}B--3F) and deregulated the expression of transcription factors and structural proteins, typical markers of dopaminergic neurons ([Figures 3](#fig3){ref-type="fig"}G--3K, [S2](#mmc1){ref-type="supplementary-material"}A, and S2B). These results indicate that suppression of L1 dynamics affected fibroblast conversion into iDA cells, which underscores a supportive role played by L1 retrotransposition in this process. Notably, a TaqMan multiplex qPCR assay on both RNA and genomic DNA showed that FANA ASOs efficiently prevented full-length L1 transcript accumulation and retrotransposition, although lamivudine prevented only the expansion of L1 without affecting L1 expression ([Figures 3](#fig3){ref-type="fig"}D--3F). To exclude possible biases due to 3TC toxicity, we controlled cell viability in mock and 3TC-treated cells with propidium iodide-based cell-cycle fluorescence-activated cell sorting analysis, reporting no effects ([Figure S2](#mmc1){ref-type="supplementary-material"}C). Finally, the transfection of an exogenous L1-ASO-resistant mouse active L1 element (pTNC7 plasmid, kindly donated by Edith Heard) partially rescued the transdifferentiation rate in MEF cells treated with L1 ASO ([Figure S2](#mmc1){ref-type="supplementary-material"}D).

Whole-Genome Sequencing Reveals a Specific L1 Insertion Profile in the Genome of iDA Cells {#sec2.3}
------------------------------------------------------------------------------------------

Next, we investigated the consequences at the genome-wide level of L1 reactivation. To map L1 retrotransposition events in the genome of the reprogrammed cells, we performed WGS on parental MEF cells, sorted TH+ iDA neurons and lamivudine-treated TH+ cells. WGS data were filtered with Mobster ([@bib18], [@bib52]) to search for active, non-reference mobile element insertions (MEIs), taking the MEF genome as reference. From this first list ([Figure S3](#mmc1){ref-type="supplementary-material"}A), we isolated the anchors containing L1 elements present uniquely in the iDA cell genome and discarded those shared with the MEF parental cells. Furthermore, we considered only the insertions supported by at least five reads from both the 5′ and 3′ junctions, common to at least two biological replicates and with less than 50-bp of insertion shift between replicates. Further, for each insertion, we verified the presence of target site duplications/deletions, target size duplication sequences, the L1 truncation pattern, the motif of the L1 insertion site, and the allelic frequency ([Data S1](#mmc2){ref-type="supplementary-material"}).

We cataloged about 800 intergenic and 111 intragenic (intronic) insertions unique to the iDA cell genome and undetectable in MEF and 3TC-treated cells; more than the 90% of the insertions were from L1MdGf, L1MdA, L1MdTf, and L1MdF elements ([Figures 4](#fig4){ref-type="fig"}A--4C). Most of the insertions were consistent among biological replicates in terms of genomic location, indicating a non-random L1 somatic insertion profile ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C). Gene ontology analysis showed that the 111 acceptor genes found in iDA cells were enriched for neuronal functions ([Figure 4](#fig4){ref-type="fig"}D), while the few genes receiving insertions in MEFs or 3TC-treated cells are not involved in neuronal functions. This included the *Dlg2* neuronal gene, reported in previous studies to be an L1 acceptor gene ([@bib15], [@bib43]). The calculated average frequency per cell was (∼0.3) in line with the detected range shown in other reports ([Data S1](#mmc2){ref-type="supplementary-material"}) ([@bib17], [@bib16], [@bib46], [@bib53]).Figure 4Analysis of L1 *De Novo* Insertions in Reprogrammed and Lamivudine-Treated Cells(A) Whole genome sequencing data of the distribution of L1 somatic insertions supported by more than five reads on each of 5' and 3' ends of inserted sites that were consistently inserted in more than two replicates between 0 and 50 base pairs in different replicates. SEM is indicated in the plot. n = 3.(B) Representation of the frequency of retrotransposition of L1 subfamilies in iDA cells genome.(C) Venn diagram showing different intragenic L1 *de novo* insertion rates.(D) Functional analysis of L1 acceptor genes specific to MEF, iDA and 3TC-treated iDA cells using Gene Ontology.(E) L1 insertion site motif LogoPlot.(F) percentage of full length *de novo* inserted L1s.(G) Truncation pattern of L1 somatic insertions.(H) Target Size Duplication (TSD) size distribution. Table showing PCR validation results of 16 L1s somatic insertions.(I) Selected L1 insertions used for PCR validation.See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.

For validation, we randomly selected 16 candidate loci of the junction between the 5′ end of the *de novo* inserted L1 element and the flanking genome. Thirteen of 16 candidate insertions were successfully PCR amplified on DNA from an independent experiment and Sanger sequenced to control the structure of the junction between the L1 and the flanking genome ([Figure 4](#fig4){ref-type="fig"}I, [Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). No residual insertion amplification in both MEF cells and TH+ 3TC-treated cells has been detected ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). In addition, few insertions were further validated through an empty/filled locus amplification screening. The acceptor site containing a retrotransposed L1 element was amplified in each iDA replicate and the heavier locus band Sanger sequenced ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Taken together, these results show that neuronal fate induction is accompanied by L1 retrotransposition, affecting regions of the genome, relevant for neuronal lineage commitment and neuron function.

L1 Retrotransposition Follows the Specificity of Neuronal Gene Expression Profile {#sec2.4}
---------------------------------------------------------------------------------

The impact of L1 somatic retrotransposition on the neuronal genetic program remains to be understood. Using RNA-seq analysis of MEFs, iDAs, and 3TC-treated cells, we sought to investigate the connection between the L1 *de novo* insertion profile and the iDA cell differentiation program. Among all genes that accepted L1 insertions, 32% were differentially expressed in transdifferentiated cells ([Figures 5](#fig5){ref-type="fig"}A and 5B). We also looked into the transcriptional behavior of genes proximal to L1 acceptor genes to see if L1 insertions exerted any influence on nearby genes, but we could not find any specific transcriptional pattern ([Figure S5](#mmc1){ref-type="supplementary-material"}B).Figure 5*De Novo* Insertions Support the Establishment of a Cell-Type-Specific Gene Expression Profile that Is Disrupted upon Lamivudine Treatment(A) Differential expression analysis of iDA-specific acceptor genes showing up, down, and not differentially expressed. False discovery rate (FDR) of 0.05 and a minimum fold change of 2 on a log2 scale have been considered in the analysis.(B) Gene Ontology analysis of up- and down-regulated L1 acceptor genes.(C) RNA-seq pathway analysis of differentially expressed pathways in iDA neurons compared with MEF cells.(D) RNA-seq pathway analysis of differentially expressed pathways in 3TC-treated iDA neurons compared with mock iDA neurons.(E) ATAC-seq analysis results at intergenic L1 recipient loci in iDA and 3TC treated cells at different distances from the insertion site; t tests are indicated. n = 3.(F) Quantification of novel non-coding transcripts produced within ±100, ±500, ±1,000 bp from the somatic L1 element in iDA and 3TC-treated iDA neurons. SEM and t test are indicated. n = 3.(G) Total amount of long non-coding transcripts produced in MEF and transdifferentiated cells within ±1,000 bp of *de novo* inserted and germline L1 elements. SEM and t test are indicated in the plot. n = 3.(H) RNA-seq *de novo* assembly transcriptome analysis of MEF, iDA, dopaminergic neurons, and 3TC treated iDA cells. The percentage of non-coding transcripts longer than 200 bp has been normalized over the whole transcriptome. SEM and two-tailed t test are indicated in the plot. n = 6.See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

A comparison between the most significantly represented pathways (Kyoto Encyclopedia of Genes and Genomes database) in iDA neurons and MEF cells reveals that transdifferentiation produces a radical change in cell structures and functions ([Figures 5](#fig5){ref-type="fig"}C and [S5](#mmc1){ref-type="supplementary-material"}C). Conversely, L1 inhibition during the transdifferentiation process prevents upregulation of the pathways required for dopaminergic neuron functionality, reflecting incomplete cell conversion ([Figures 5](#fig5){ref-type="fig"}D and [S5](#mmc1){ref-type="supplementary-material"}C).

The somatic insertion of an engineered L1 element was shown to increase the expression of the neuron-specific recipient gene ([@bib43]). A possibility could be specific changes in chromatin accessibility. To test this hypothesis, we used ATAC-seq analysis ([@bib5]) to compare the chromatin structure next to L1 acceptor sites in iDA cells and 3TC-treated cells, which share the same culture conditions and overexpression of the same lineage-specific transcription factors but differ only for L1 insertions profile. Notably, to avoid interference of induced active genes, we selected acceptor loci far from known transcribed units. ATAC-seq analysis showed an increased chromatin accessibility of recipient loci when L1 somatic insertion was present ([Figure 5](#fig5){ref-type="fig"}E).

L1 elements might be capable of tuning cell-type-specific expression by acting as regulatory sequences ([@bib23], [@bib24]) and creating new transcription units ([@bib9], [@bib34], [@bib36]). The finding that L1 somatic insertions in iDA cells correlate with more open chromatin and nearby long non-coding RNA (lncRNA) production is in line with the previously reported connection between retrotransposons and evolution of lineage-specific lncRNAs ([@bib30], [@bib33]). We performed transcriptome assembly from RNA-seq data, and we measured the percentage of the global long non-coding transcriptome. In iDA cells, compared with MEFs, we detected an increase (8%--10%) of the global non-coding transcriptome consistent with the increase in the L1 number of copies ([Figure 5](#fig5){ref-type="fig"}F). Transdifferentiated 3TC-treated cells showed a reduced level of non-coding transcripts. We also compared the novel non-coding transcripts detected in iDA neurons with previously published RNA-seq data of midbrain dopaminergic neurons. Further, iDA and midbrain dopaminergic neurons share an equivalent global amount of long non-coding transcripts ([Figure 5](#fig5){ref-type="fig"}F) (PRJNA271250) ([@bib3]).

To correlate lineage-specific L1 insertions, chromatin accessibility and transcription, we analyzed lncRNA expression at distances as close as 100 bp, 500 bp, and 1 kb around all L1 insertion sites and measured the number of transcripts produced in iDA cells and 3TC-treated cells. We detected *de novo* or increased production of non-coding RNAs at 500 bp and 1,000 bp in iDA- compared with 3TC-treated cells ([Figure 5](#fig5){ref-type="fig"}G). None of the non-coding transcripts contained portions of L1 sequences.

We further investigated the rate of non-coding RNA expression from intergenic regions flanking a *de novo* inserted L1 element or a germline L1 element. This analysis showed a significantly increased production of long non-coding transcripts around somatic L1 insertions loci in iDA cells compared with the same loci devoid of L1 in MEFs ([Figure 5](#fig5){ref-type="fig"}H). In contrast, regions flanking a germline L1 element, present in both MEF and iDA cells, do not show different lncRNA expression upon transdifferentiation ([Figure 5](#fig5){ref-type="fig"}H).

We conclude that L1 somatic insertions strongly correlate with both a more open chromatin state of recipient loci and lncRNA production in close proximity to the *de novo* insertion sites.

Discussion {#sec3}
==========

As L1 reactivation appears to follow brain development, our work addressed the question whether L1 retrotransposition would accompany neuronal cell specialization also in a direct transdifferentiation context. We found that reactivation of the dynamics of L1 elements is elicited in the initial stages of MEF reprogramming and accompanies cell maturation to the complete acquisition of the fate of dopaminergic neurons ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). When retrotransposition was prevented, the efficiency of conversion of MEFs to iDA cells was severely impaired, as confirmed by immunofluorescence staining, RT-qPCR analysis of transdifferentiation markers, and RNA-seq-based signaling pathway analysis ([Figures 3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, and [5](#fig5){ref-type="fig"}).

In order to gain a closer estimate of the *de novo* insertions, we performed paired-end WGS. The selection of reliable analytical methods for L1 somatic variant identification in the genome has been a debated topic. In particular, doubts have been raised about identification of false-positive events generated by targeted sequencing approaches or single-cell sequencing coupled with a massive whole-genome amplification. The PCR-free WGS approach excluded biases introduced by the capturing of non-specific DNA sequences or PCR amplification. Moreover, the Mobster tool used for WGS data analysis mapped MEIs with a high level of confidence, limiting the number of false positives ([@bib17], [@bib18], [@bib52]).

iDA cells showed an accumulation of L1 somatic insertions after transdifferentiation with an average allelic frequency of 0.3 ([Figure 4](#fig4){ref-type="fig"}), in line with recently reported studies ([@bib15], [@bib17]). Further, Gene Ontology analysis of the 111 intragenic insertions present only in iDA cells revealed a preference for insertions into lineage-specific active genes, in keeping with previous observations and correlations between L1 retrotransposition and mental disorders ([@bib15], [@bib54]). The presence of cell-specific somatic insertions and recurring among individuals has been described recently in *Drosophila* oocytes for both LTR and LINE-type transposons ([@bib55]).

TEs spreading in intergenic regions and evolution of both regulatory elements and lncRNAs appear to be tightly linked, indicating a key contribution of TEs sequences in influencing somatic gene regulatory networks ([@bib9], [@bib28], [@bib30], [@bib33], [@bib34], [@bib36], [@bib50]). As a possible impact of the L1 insertion on gene expression, we integrated the WGS data with RNA-seq data. In the iDA cells, one-third of the genes carrying L1 insertion cells appeared to be differentially expressed ([Figures 5](#fig5){ref-type="fig"}A--5D) following the induced phenotypic change of the cell. Conversely, lamivudine-treated cells, despite priming by overexpression of lineage-specific transcription factors, did not accumulate L1 at the same loci and failed to reprogram to dopaminergic cell fate ([Figures 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, and [S5](#mmc1){ref-type="supplementary-material"}A; [Data S1](#mmc2){ref-type="supplementary-material"}). Through ATAC-seq analysis, we provide evidence that L1 acceptor sites are more accessible upon insertion than 3TC-treated cells lacking L1 retrotransposition ([Figure 5](#fig5){ref-type="fig"}E). The integration of WGS and ATAC-seq with RNA-seq suggests that enhanced chromatin activity due to L1 retrotransposition might elicit the expression of novel non-coding transcripts ([Figures 5](#fig5){ref-type="fig"}F--5H) as proposed also in other reports. Future work will shed light on the mechanistic link between L1 reactivation and activation of lineage-specific genetic programs, a theme relevant for direct cell reprogramming-based technologies and their applications.

Experimental Procedures {#sec4}
=======================

iDA Cells Reprogramming {#sec4.1}
-----------------------

MEF transdifferentiation experiments were performed as described in [@bib7]. Third-generation lentiviral vectors containing the coding sequence of *Nurr1, Ascl1*, and *Lmx1a* transcription factors under the control of the tetracycline operator were packaged in 293T cells. MEF cells containing the TH-EGFP reporter cassette (25,000 cells/cm^2^) were infected in MEF medium (DMEM; Gibco) containing 10% fetal bovine serum (Gibco), non-essential amino acids (Gibco), sodium pyruvate, and penicillin/streptomycin (Gibco). At 16--20 h after infection, cells were switched into fresh MEF medium containing doxycycline (2 mg/mL; Sigma). After 48 h, the medium was replaced with serum-free neuronal-inducing medium: DMEM/F12 (Gibco), 25 μg/mL insulin (Sigma), 50 μg/mL transferrin (Sigma), 30 nM sodium selenite, 20 nM progesterone (Sigma), 100 nM putrescine (Sigma), and penicillin/streptomycin (Sigma) containing doxycycline. Lamivudine (3TC, Sigma; 10 mg/mL in PBS), at a final concentration of 150 μM, was added to proliferating fibroblasts after lentiviral infection until the end of transdifferentiation, and the medium was refreshed every 24 h. A mock experiment was performed with an equal volume of PBS. Cell transdifferentiation was induced with doxycycline the day after the initial 3TC treatment.

GFP^+^ TH-GFP MEF cells were sorted with a BD FACSAria III. Wild-type MEFs were used as negative control for the gating of the cell sorter.

Retrotransposition Assays and Antisense Oligonucleotide Delivery {#sec4.2}
----------------------------------------------------------------

Primary MEFs were electroporated with plasmid pGF21 and pTN201 (kindly provided by John Goodier, Johns Hopkins University) using a Neon Electroporator (Life Technologies; program: 1,650 V, 30 ms pulse) expressing an active L1 element with the neomycin resistance cassette inside its 3′ UTR ([@bib45]). After transfection, confluent cells were transdifferentiated and collected after 14 days of transdifferentiation. Control MEF cells were collected 14 days post transfection. Transfection efficiency was monitored with a GFP track plasmid (Addgene no. 30456).

FANA (2-deoxy-2-fluoroarabinonucleic acid)-modified antisense oligonucleotides specific for four different LINE-1 ORF1 regions was delivered by gymnosis following the manufacturer's instructions (AUMbiotech). Scramble antisense oligonucleotide was used as control. LINE1 RNA knockdown efficiency was controlled by TaqMan PCR. L1-specific antisense oligonucleotide sequences were as follows: L1-ASO \#1, TTG ACC TTT CTC CCT TAC TGC; L1-ASO \#2, ATA TGT TAC TTG ACC TTT CTC; L1-ASO \#3, TGT AAT TCT GAT AGG CCT TCC; L1-ASO \#4, AGT GTC TGT ATA ACA TCT GTC.

DNA Extraction and Quantification {#sec4.3}
---------------------------------

High-molecular-weight genomic DNA was isolated using standard phenol-chloroform-isoamyl alcohol (Sigma-Aldrich) extraction techniques. Extracted DNA size and quality were verified with a NanoDrop spectrophotometer and 0.8% agarose gel electrophoresis. After quantification with Quant-iT PicoGreen dsDNA kit (Thermo Scientific), genomic DNA (gDNA) was diluted to a final concentration of 1 ng/μL RNase (RNase Cocktail, Invitrogen) and Exonuclease 1 (Thermo Scientific) treatment.

RNA Extraction and cDNA Preparation {#sec4.4}
-----------------------------------

Total RNA was extracted with an RNeasy Mini kit plus (QIAGWN) according to the manufacturer\'s instructions. RNA quality and concentration were checked with the NanoDrop spectrophotometer. cDNA was produced from 100 ng of RNA from each sample with a Superscript III first-strand cDNA synthesis system (Thermo Fisher).

Gene Expression Analysis {#sec4.5}
------------------------

Real-time PCR analyses were performed with 7900HT Fast Real-Time PCR (Applied Biosystems).

Quantitative PCR was performed using Sybr Select Master mix (Life Technologies) and Ct values were calculated by 7900HT Fast Real-Time PCR RQ manager software (Applied Biosystems). Quantification was normalized as ΔCt between the gene of interest and the housekeeping gene *Tbp*. Primer sequences used in the analysis were as follows (5′-3′): m-*Tbp*-fw, CTT CCT GCC ACA ATG TCA CAG; m-*Tbp*-rev, CCT TTC TCA TGC TTG CTT CTC TG; m-*En1*-fw, CGC CTG GGT CTA CTG CAC A; m-*En1*-rev, TCT TCT TTA GCT TCC TGG TGC G; m-*Foxoa1*-fw, GAA GGG CAT GAG AGC AAC GA; m-*Foxoa1*-rev, ACA GGG ACA GAG GAG TAG GCC; m-*Foxoa2*-fw, ACG AGC CAT CCG ACT GGA G; m-Foxoa2-rev, GGC GTT CAT GTT GCT CAC G; m-*Tuj1*-fw, CAG GCC CGA CAA CTT TAT CT; m-*Tuj1*-rev, CTC TTT CCG CAC GAC ATC TA; m-*Th*-fw, CTC ACC TAT GCA CTC ACC CGA; m-*Th*-rev, GGT CAG CCA ACA TGG GTA CG.

TaqMan PCR for L1 Expression and CNV Analysis {#sec4.6}
---------------------------------------------

Quantitative PCR experiments were performed on a 7900HT Fast Real-Time PCR (Applied Biosystems) apparatus. L1 genomic content was measured by multiplex qPCR TaqMan assay with probes specific for L1-ORF2 and M-Satellite DNA (SATA) as internal control. In each reaction, two TaqMan probes, labeled with FAM and VIC fluorophores, were combined with 1 ng of gDNA, target-specific primers, and iQ multiplex Powermix (Bio-Rad) in a total volume of 20 μL. Tbp TaqMan premade assay was used as an internal normalizer (Thermo Fisher catalog no. 4333769F). TaqMan probes and primers for LINE-1, 5s rDNA, SINE-B1, SINE-B2, and IAP transposable element expression, and CNVs are described in [@bib2].

Immunofluorescence Assay {#sec4.7}
------------------------

Immunofluorescence assays were performed as described in [@bib7]. Primary antibodies used TH (Millipore ab-152), TUJ1 (Abcam ab-18207, [www.abcam.com/beta-III-Tubulin-antibody-ab18207.pdf](http://www.abcam.com/beta-III-Tubulin-antibody-ab18207.pdf){#intref0010}), VMAT2 (Chemicon, ab1598p). Detection was performed for 40 min at room temperature with the following secondary antibodies: goat-anti-mouse immunoglobulin (Ig)G (Alexa Fluor 594; Thermo Scientific); chicken anti-rabbit IgG (Alexa Fluor 488; Thermo Scientific), dilution 1:1,000. Nuclei were stained with a dilution of 1:5,000 of 5 mg/mL DAPI solution.

A scale bar is indicated in each image, and the dimension of the scale bar is specified in the figure legend.

Western Blot {#sec4.8}
------------

Total protein extracts were prepared by lysing cells in extraction buffer (HEPES KOH \[pH 8.5\], NaCl 400 mM, EDTA 0.1 mM, EGTA 0.1 mM, DTT 1 mM, 1× protease inhibitor, SDS 1%). Proteins were separated by electrophoresis on BOLT 4%--12% bis-tris polyacrylamide precast gels in MOPS buffer (Life Technologies). Anti-mLINE1-ORF2 (custom made, Eurogentek) was raised in guinea pigs against the mouse-specific C-term of the LINE-1 ORF2 protein (details and ELISA test available upon request), anti-mouse L1-ORF1 (Abcam EPR21844-108), anti-TBP (Santa Cruz Biotechnology, SC-273). Horseradish peroxidase-conjugated secondary antibodies were revealed with the ECL chemoluminescence kit (Amersham) and signals detected with ChemiDoc (Bio-Rad).

Northern Blot {#sec4.9}
-------------

Total RNA was extracted as before and poly(A)+ transcripts were isolated with a poly(A) spin RNA isolation kit (NEB S1560S). Isolated poly(A)+ RNA was run on a 2% agarose denaturing gel (Thermo Scientific \#AM8678). Northern blot was performed using the NorthermMax-Gly Kit (Thermo Scientific \#AM1946--\#AM8672). Nylon membrane was hybridized at 39°C with 21-nt-long biotinylated probes (designed and produced by Stellaris-LGC Bioscience) complementary to the 0--600 bp region of the mouse L1 5′ UTR. β-Actin predesigned RNA probes were used as loading control following the manufacturer's instructions (Sigma-Aldrich \#11498045910). The signal was revealed using a chemiluminescent Nucleic Acid Detection Kit (Thermo Scientific \#89880) and chemiluminescence was detected with ChemiDoc (Bio-Rad)

Genomic DNA Library Preparation, Whole-Genome Sequencing, and Analysis {#sec4.10}
----------------------------------------------------------------------

Genomic libraries were prepared using a PCR-free Illumina TruSeq LT DNA kit. DNA was extracted from MEFs, induced dopaminergic cells transdifferentiated until day 14 (iDA14), and transdifferentiated cells treated with reverse transcriptase inhibitor lamivudine (3TC; Sigma-Aldrich) (iDA14 + 3TC). Sequencing was performed using an Illumina HiSeq2000 sequencer (KAUST Core Lab) (45× minimum coverage). For quality control, we used FastQC ([www.bioinformatics.babraham.ac.uk/projects/fastqc/](http://www.bioinformatics.babraham.ac.uk/projects/fastqc/){#intref0015}) and Trimmomatic v0.38 (<http://www.usadellab.org/cms/?page=trimmomatic>). Genomic reads were then mapped to the *Mus musculus* (mm10) reference genome using the BWA v0.7.17 genome aligner (<http://bio-bwa.sourceforge.net/>) ([@bib37], [@bib38]) with default parameters. The resulting Bam files were used as input to Mobster v0.1.6 ([sourceforge.net/projects/mobst](http://sourceforge.net/projects/mobst){#intref0030}) ([@bib52]) to predict and characterize *de novo* MEIs and their genomic position as previously reported. Briefly, Mobster searches for candidate active non-reference MEIs using discordant read pairs with at least one uniquely mapped read (anchors for the possible insertion). Mates of the anchoring reads are then mapped to consensus ME sequences. We obtained LINE1 consensus sequences from RepeatMasker v4.0.7 (<http://www.repeatmasker.org/>) ([@bib49]) and the RepBase database ([@bib31]) (<http://www.girinst.org/>). Anchors in the same strand and supportive of the same ME family were clustered together. Then, forward-strand and reverse-strand clusters indicative of the same MEI event are joined. To avoid predicting MEIs already present in the reference, all predictions are filtered with a prediction window within 90 bp of an annotated MEI of the same ME family as the predicted MEI. Mobster results were further filtered to isolate only insertions supported by at least five reads and common between at least two biological repeats for each sample. Karyotype was controlled using Aneufinder with standard parameters.

For downstream validations, we reconstructed a virtual reference genome for each predicted insertion and designed primers across each MEI junction between the 5′ end of the L1 and the flanking genome.

PCR Validation of De Novo LINE1 Insertions {#sec4.11}
------------------------------------------

Candidate *de novo* insertions from WGS were validated by PCR on high-molecular-weight genomic DNA (15--20 kb average size) obtained from MEF cells, iDA cells, and 3TC-treated cells. For this assay, a forward primer was designed on the genomic flanking region and a reverse primer on the 5ʹ end of the *de novo* inserted LINE1 element to produce amplicons with size between 200 and 300 bp. PCR was performed with Q5 HF 2× master mix (NEB). PCR products were analyzed with standard 2% agarose gel electrophoresis (Bio-Rad). Image acquisition was performed with the ChemiDoc image system (Bio-Rad). PCR fragments were cloned into an entry vector using a TOPO-TA cloning kit (Life Technologies) and Sanger sequenced to verify the sequence of LINE-1 *de novo* insertion sites. Primers used for validations were as follows (5′-3′): SI-1 FW TGT CGG GCA GAG AGA GCT; SI-1 REV ATT TCC TAA GTT CGG CGG GT; SI-2 FW ACC GTA GTG TCC AGT TTT CAA C; SI-2 REV GAG TCA CGA GTC GAG CGG; SI-3 FW TCC ACA CCA ATA GAC AGC CG; SI-3 REV GAG TCC CGG AGC CAA GAA G; SI-4 FW ATG GCT ACA GTT CCG CAC AT; SI-4 REV CGC ACC CTC TAA CCT GTT CA; SI-5 FW TGT GTG TGT GTC CAA AAT GCA; SI-5 REV AGC CTG CTT CCC TAT GTA CC; SI-6 FW TCT GAG ATG GAC CCT AGG CT; SI-6 REV CGG ACC CCT GTG CTC TCA; SI-7 FW TGT TCT TGG ATG CGA CAC AA; SI-7 REV GGT AGC CTG CTT CCC TAT GT; SI-8 FW AGG CAT CTG TGA ATC TTT CTA CA; SI-8 REV GTT GTC TGG AGC CGA AGA TG; SI-9 FW TGG GTG ATG GTT TGG ATC CT; SI-9 REV ACT TGT GCC CCA GAT CAG G; SI-10 FW AAG GAA GGC TAC TGA TTT GTT TG; SI-10 REV GGT TGT CTG GAG CCG AAG AT; SI-11 FW CCA CAG AAT ACC TAC AAA TGA GC; SI-11 REV AGC CTG CTT CCC TAT GTA CC; SI-12 FW TCC CCT TAC AGC CAA CTT CA; SI-12 REV GGA CTT GTG CCC CAG ATC A; SI-13 FW GGG AGC AGG CAG AAA ATT CA; SI-13 REV CGG ACC CCT GTG CTC TCA; SI-14 FW GAA GGC TAC TGA TTT GTT TGA GT; SI-14 REV GGA AGG TGG CTG GTT GTC T; SI-15 FW CCA CAG AAT ACC TAC AAA TGA GC; SI-15 REV GGC CCG GGT AGC CTG CTT CC; SI-16 FW CCC ACA TCC TCC CAA CAT CT; SI-16 REV ATT CTT GGA GCT GGT GTT GC. For empty/filled PCR validation, primers were designed on the reference DNA to amplify 100 bp flanking the insertion site (empty locus) ([Data S1](#mmc2){ref-type="supplementary-material"}). The band corresponding to the locus with the putative L1 insertion (filled locus) was TA-cloned and Sanger sequenced using M13 forward and M13 reverse primers.

Chromatin Tagmentation {#sec4.12}
----------------------

Chromatin tagmentation of MEF cells, iDA cells, and 3TC-treated cells was performed as previously described ([@bib5]). Tagmented chromatin was deep sequenced with an IlluminaHiSeq4000 machine, and data were analyzed using the chipseeker tool with standard parameters.

RNA Library Extraction and Transcriptome Sequencing {#sec4.13}
---------------------------------------------------

Total RNA was isolated from MEF cells, iDA14 cells, and 3TC-treated cells, with three biological replicates each sample. RNA-seq libraries were prepared using an Illumina TruSeq Total RNA library preparation kit (Illumina) following the manufacturer's instructions. The total RNA library preparation employed a ribosomal removal step using a Ribo-minus kit (Illumina). Ribosomal depleted RNA was then used for downstream library preparation following Illumina\'s protocol. Quality control and quantification of the libraries were performed using Qubit 3.0 (Life Technologies) and Bioanalyzer Chip RNA 6000 pico (Agilent), and they were sequenced directly using the high-throughput Illumina HiSeq 2500 sequencing system (KAUST Core Lab). The transcriptomic data were aligned to the mm10 reference genome using Tophat v2 ([ccb.jhu.edu/software/tophat/index.shtml](http://ccb.jhu.edu/software/tophat/index.shtml){#intref0045}) and Bowtie v2 (<http://bowtie-bio.sourceforge.net/index.shtml>). Cufflinks v2.2 ([@bib25]) (<http://cole-trapnell-lab.github.io/cufflinks/>) was used to assemble and quantify transcript expression.

Transcriptome assembly, mapping, and quantification were done using the Trinity v2.4.0 tool ([github.com/trinityrnaseq/trinityrnaseq/wiki](http://github.com/trinityrnaseq/trinityrnaseq/wiki){#intref0060}) following standard parameters. The transcripts from each assembly were then mapped to virtual references and the list of both chimeric and non-chimeric transcripts were collected for further analysis. The mapped transcripts were then checked with blast against the mm10 reference RNA database for similarity with any existing ncRNAs. To assess the coding potential of Trinity-assembled transcripts, they were mapped to protein coding transcripts and classified as coding or non-coding.

Cuffdiff v2 (<http://cole-trapnell-lab.github.io/cufflinks/cuffdiff/>) was used for the differential expression analysis; CummeRbund and the R v3.4.1 package were used to visualize the expression of the set of transcripts of interest.

Gene Ontology and pathway analysis were done using GOseq (<https://bioconductor.org/packages/release/bioc/html/goseq.html>). To compare the compatibility of our transdifferentiated transcriptome with *in vivo,* we used open-source MEF and dopaminergic data for the mouse genome from NCBI.

Statistical Analysis {#sec4.14}
--------------------

In bar plots, values are presented as means and SEM; number of replicates are indicated in the figure legends (at least n = 3). To determine the significance between two mean values, we made comparisons by two-tailed t test. Comparisons among three or more samples were done by one-way ANOVA. For all statistical tests, a 0.05 level of confidence was accepted for significance. All the statistical analyses were performed with GraphPad Prism7 software.
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Accession Numbers {#app1}
=================

All raw Illumina next-generation sequencing data have been deposited at the BioProject database, which is hosted at the NCBI, under the BioProject Database accession number: PRJNA388561. <http://www.ncbi.nlm.nih.gov/bioproject/388561>.

Supplemental Information {#app3}
========================

Document S1. Figures S1--S5Data S1. Mobster WGS Analysis ResultData S1 contains the complete list of LINE-1 de novo insertions called with Mobster WGS analysis in MEF, iDA and 3TC treated cells.The table contains the insertions coordinate, Subfamily of L1 inserted, insertion annotation, presence of Target site duplication or deletion, sequence of the TSD, sequences of the genome flanking the insertion site, start/end point of the L1 element inserted, sequence of the assembled virtual reference and allelic frequency of the event in each biological replicate with specified the number of reads supporting the insertion and the total reads from the locus.Document S2. Article plus Supplemental Information
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